Palisade Bio PALI
NASDAQ PALI
$2.09 +0.04 (+2.20%)
At close: Sep 4, 2026 · 4:00 PM EDT

Palisade Bio (PALI) EBT Margin (2011 - 2026)

Palisade Bio (PALI) posted quarterly EBT Margin of 15269.2% for Q1 2023, up 88.89% quarter-over-quarter from 137416.12% in Q4 2020.

Analysis

Palisade Bio (PALI) EBT Margin (2011 - 2026) Analysis & Trends

Palisade Bio (PALI) has reported EBT Margin for 11 consecutive years, with 15269.2% the latest figure, recorded in Q1 2023.

  • In Q1 2023, EBT Margin changed N/A year-over-year to 15269.2%; the TTM figure through Dec 2023 stood at 19498.0% (changed N/A YoY), while the FY2023 annual figure was 16808.8%, changed N/A from the prior year.
  • EBT Margin improved to 15269.2% in Q1 2023 per PALI's latest filing, from 137416.12% in the prior quarter.
  • Across five years, EBT Margin topped out at 15269.2% in Q1 2023 and bottomed at 137416.12% in Q4 2020.
  • Historically, EBT Margin has averaged 70880.01% across 3 years, with a median of 75960.88% in 2020.
  • On a YoY basis, EBT Margin climbed as much as 5895662 bps in 2020 and fell as far as 5243968 bps in 2020.
  • Palisade Bio's EBT Margin stood at 84976.44% in 2019, then sank by 62 bps to 137416.12% in 2020, then soared by 89 bps to 15269.2% in 2023.
  • Business Quant data shows PALI's EBT Margin at 15269.2% in Q1 2023, 137416.12% in Q4 2020, and 73918.76% in Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 35.61%
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 35.78%
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -528.97%
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 18.33%
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 13.77%
8 Royalty Pharma 28.45 Bn 27.61 Bn - 12.09%
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -2.67%
10 Palisade Bio 440.73 Mn 315.53 Mn - -2,339.60%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,339.60%
Mar 31, 2023 -1,011.60%
Dec 31, 2020 -137,416.12%
Sep 30, 2020 -73,450.76%
Jun 30, 2020 -73,700.24%
Mar 31, 2020 -32,886.28%
Dec 31, 2019 -84,976.44%
Sep 30, 2019 -84,434.16%
Jun 30, 2019 -24,170.71%
Mar 31, 2019 -97,183.28%
Dec 31, 2018 -71,377.00%
Sep 30, 2018 -82,662.12%
Jun 30, 2018 -793.75%
Mar 31, 2018 -93,326.64%
Dec 31, 2017 -893.05%
Sep 30, 2017 -102,846.28%
Jun 30, 2017 -168,797.84%
Mar 31, 2017 -173,994.24%
Dec 31, 2016 -66,623.67%
Sep 30, 2016 -205,606.96%